'Flying for Life' Blood Drive takes flight
The Flying for Life Blood Drive took flight Monday at KELO-TV, with the first of six days' worth of collection events.
Dry, hot and windy weather impacting trees
'This friendly competition between Avera Careflight and Sanford AirMed began several years ago during COVID when we really didn't know where we were going to go with the ability to collect blood as we prepare for the summer months,' Community Blood Bank Executive Director Ken Versteeg said.
Versteeg says the competition is also an opportunity to honor our high-flying first responders.
'I can't even describe the amount of stress that they go through every single day when they come to a site and they have an emergency that they have to address. These are the first people that see an individual and determine if they need a blood transfusion or not,' Versteeg said.
There are six units of O-negative blood, also known as the universal donor and rarest of blood types, on every flight.
'Everybody that asks me my blood type, it's like 'O-negative' and they say 'oh, you're one of the lucky ones' (laughs),' Brandon resident Kathy Van Santen said.
Van Santen is part of the 7% of the population with O-negative blood, but encourages everyone — whatever your blood type — to give.
'Because it's actually a needed thing in the communities, so yeah, if you're able, willing and able to do that, just give it a try, it's not that bad,' Van Santen said.
And the timing of Flying for Life is no mistake. Community Blood Bank requires 550 units of blood every week to meet the needs of its local hospitals, and finding donors during the summer can prove difficult.
'This is the time of year where people forget about donating blood because their lives are so busy with the graduation ceremonies and then the vacations and then they might have family activities outside, but take the time to donate a unit of blood,' Versteeg said.
It could save a life.
The Flying for Life Blood Drive continues at 7 on Tuesday morning at GreatLIFE at Avera McKennan Fitness Center in Sioux Falls.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
How did John MacArthur die? What we know about pastor's cause of death
John MacArthur, the longtime pastor of a megachurch in Southern California and founder of a syndicated media ministry, died July 14 after being hospitalized with pneumonia. "Our hearts are heavy, yet rejoicing, as we share the news that our beloved pastor and teacher John MacArthur has entered into the presence of the Savior," MacArthur's media ministry, Grace to You, wrote on social media. "This evening, his faith became sight." MacArthur, 86, was the pastor at Grace Community Church, a nondenominational congregation in Sun Valley, California, a post he held since 1969. Tom Patton, another pastor at Grace Community Church, said at a July 13 service that MacArthur had been hospitalized after contracting pneumonia. USA TODAY has reached out to Grace Community Church. MacArthur's cause of death has not been announced, though he had been hospitalized with pneumonia in his final days, Patton said. "This week pastor John contracted pneumonia," Patton said. "He was admitted into the hospital and may be in the presence of the Lord soon." A message on Grace Community Church's website noted the same about MacArthur's condition. "Last week, Pastor John unexpectedly contracted pneumonia, and the Lord took him home on Monday, July 14," the message said. A message on Grace to You's website said MacArthur died "after dealing with some significant health challenges dating back to early 2023." "Just as the details of John's death are new to you, they are new to us as well. We probably have many of the same thoughts and feelings that you do," Grace to You's website said. USA TODAY has reached out to the Los Angeles County Medical Examiner's office for more information. Grace to You's website also said there are currently no details about services for MacArthur. John MacArthur was a pastor and author known for leading Grace Community Church in Sun Valley, California, and for his work with the media ministry Grace to You. He was also the longtime president and chancellor of The Master's University, a private Christian university in Santa Clarita, California, and founder of The Master's Seminary in Los Angeles. MacArthur became the pastor at Grace Community Church in 1969 after graduating from Talbot Theological Seminary in California, according to his leadership bio. Throughout his career, he also wrote nearly 400 books. Like some other preachers across the U.S., MacArthur entered the public spotlight during the COVID-19 pandemic when he hosted large gatherings despite local policies limiting congregations to small numbers outside. "At the center of Dr. MacArthur's ministry was an unwavering commitment to declare God's truth, and Pastor John preached the Word in season and out of season," Grace Community Church's website says. "Even in recent years, though beset with health challenges, he persisted in teaching, leading, and investing in the ministries the Lord had entrusted to him." In addition to his wife of 61 years, Patricia, MacArthur is survived by four children, fifteen grandchildren and nine great-grandchildren. Contributing: James Powel and Natalie Neysa Alund, USA TODAY Melina Khan is a national trending reporter for USA TODAY. She can be reached at This article originally appeared on USA TODAY: How did John MacArthur die? Grace Community Church announces his death
USA Today
3 hours ago
- USA Today
How did John MacArthur die? What we know about pastor's cause of death
John MacArthur, the longtime pastor of a megachurch in Southern California and founder of a syndicated media ministry, died July 14 after being hospitalized with pneumonia. "Our hearts are heavy, yet rejoicing, as we share the news that our beloved pastor and teacher John MacArthur has entered into the presence of the Savior," MacArthur's media ministry, Grace to You, wrote on social media. "This evening, his faith became sight." MacArthur, 86, was the pastor at Grace Community Church, a nondenominational congregation in Sun Valley, California, a post he held since 1969. Tom Patton, another pastor at Grace Community Church, said at a July 13 service that MacArthur had been hospitalized after contracting pneumonia. USA TODAY has reached out to Grace Community Church. John MacArthur cause of death: What we know MacArthur's cause of death has not been announced, though he had been hospitalized with pneumonia in his final days, Patton said. "This week pastor John contracted pneumonia," Patton said. "He was admitted into the hospital and may be in the presence of the Lord soon." A message on Grace Community Church's website noted the same about MacArthur's condition. "Last week, Pastor John unexpectedly contracted pneumonia, and the Lord took him home on Monday, July 14," the message said. A message on Grace to You's website said MacArthur died "after dealing with some significant health challenges dating back to early 2023." "Just as the details of John's death are new to you, they are new to us as well. We probably have many of the same thoughts and feelings that you do," Grace to You's website said. USA TODAY has reached out to the Los Angeles County Medical Examiner's office for more information. Grace to You's website also said there are currently no details about services for MacArthur. Who was John MacArthur? About his pastoral career John MacArthur was a pastor and author known for leading Grace Community Church in Sun Valley, California, and for his work with the media ministry Grace to You. He was also the longtime president and chancellor of The Master's University, a private Christian university in Santa Clarita, California, and founder of The Master's Seminary in Los Angeles. MacArthur became the pastor at Grace Community Church in 1969 after graduating from Talbot Theological Seminary in California, according to his leadership bio. Throughout his career, he also wrote nearly 400 books. Like some other preachers across the U.S., MacArthur entered the public spotlight during the COVID-19 pandemic when he hosted large gatherings despite local policies limiting congregations to small numbers outside. "At the center of Dr. MacArthur's ministry was an unwavering commitment to declare God's truth, and Pastor John preached the Word in season and out of season," Grace Community Church's website says. "Even in recent years, though beset with health challenges, he persisted in teaching, leading, and investing in the ministries the Lord had entrusted to him." In addition to his wife of 61 years, Patricia, MacArthur is survived by four children, fifteen grandchildren and nine great-grandchildren. Contributing: James Powel and Natalie Neysa Alund, USA TODAY Melina Khan is a national trending reporter for USA TODAY. She can be reached at
New York Post
4 hours ago
- New York Post
Scientists crack the code on new vaccine for deadly plague bacteria
Israeli researchers have developed a new vaccine that is '100% effective' against bacteria that is deadly to humans. The announcement came from Tel Aviv University, which teamed up with the Israel Institute for Biological Research to create the mRNA-based vaccine, the first to protect against bacteria. 'In the study, we show that our mRNA vaccine provides 100% protection against pneumonic plague (a severe lung infection), which is considered the most dangerous form of the disease,' study co-lead Professor Dan Peer, director of the Laboratory of Precision NanoMedicine at Tel Aviv University, told Fox News Digital. 6 Illustration of the Yersinia pestis bacteria. nobeastsofierce – 'Yersinia pestis, the causative agent of plague, is considered a highly lethal infectious bacterium, against which no approved vaccine exists.' This bacterium is so lethal, even at small doses, that it's been classified as a 'Tier 1 select agent' by the CDC and is considered a 'potential bioterror weapon,' according to Peer. 'Within a week, all unvaccinated animals died, while those vaccinated with our vaccine remained alive and well,' the team reported, noting that a single dose provided full protection after two weeks. The findings were published in the journal Science Advances. Before this study, mRNA vaccines were only shown to protect against viruses, such as COVID-19, but not bacteria, according to Tel Aviv University's Dr. Edo Kon, who co-led the study. 'Until now, scientists believed that mRNA vaccines against bacteria were biologically unattainable,' said Kon in the announcement. 'In our study, we proved that it is, in fact, possible to develop mRNA vaccines that are 100% effective against deadly bacteria.' 6 A photo of Prof. Dan Peer, Dr. Inbal Hazan-Halefy, and Shani Benarroch. Tel Aviv University While vaccines for viruses trigger human cells to produce viral proteins, which then train the immune system to protect against them, that same method hasn't been effective for bacteria. Instead, the scientists used a different method to release bacterial proteins that successfully created a 'significant immune response.' 'To enhance the bacterial protein's stability and make sure that it does not disintegrate too quickly inside the body, we buttressed it with a section of human protein,' they wrote. 'By combining the two breakthrough strategies, we obtained a full immune response.' Dr. Jacob Glanville, CEO of Centivax, a San Francisco biotechnology company, reiterated the importance of the study. 6 Yersinia pestis vaccine vial and syringe. iStock 'This is distinct from research in coronavirus, influenza and cancer, which have so far been driving mRNA vaccine applications,' Glanville, who was not part of the research team, told Fox News Digital. The study shows how mRNA technologies can be rapidly applied to 'novel threat areas,' he confirmed. 'Following blowback from the mandates and rare but admittedly problematic side effects related to initial COVID-19 vaccines, mRNA as a platform has faced additional scrutiny to make sure that the next generation of vaccines to emerge from it has learned the lessons from the initial vaccines, and improved upon them,' Glanville told Fox News Digital. 'This research demonstrates yet another large application area for the technology.' Potential limitations 6 Microscopic image of Yersinia pestis bacteria. Getty Images The primary limitation of the study, according to Peer, is that the vaccine's effectiveness was shown in mice. 'As with any pre-clinical study, it needs to be evaluated in a clinical study in order to assess its effectiveness in humans,' he told Fox News Digital. In addition, the experimental mRNA vaccine is based on the 'lipid nanoparticle (LNP) mRNA vaccine platform' that was recently approved for COVID-19 vaccines, Peer noted, which requires 'cold chain logistics' (a supply chain that uses refrigeration). 'Nevertheless, extensive studies are performed in our lab, focusing on lipid formulation stability optimization that will enable room-temperature storage,' the researcher added. Looking ahead 6 The primary limitation of the study, according to Peer, is that the vaccine's effectiveness was shown in mice. motortion – The goal is for this new technology to fast-track vaccines for bacterial diseases, according to the researchers. This could be particularly beneficial for pathogenic (disease-causing) and antibiotic-resistant bacteria. 'Due to excessive use of antibiotics over the last few decades, many bacteria have developed resistance to antibiotics, reducing the effectiveness of these important drugs,' said Peer. 'Consequently, antibiotic-resistant bacteria already pose a real threat to human health worldwide. Developing a new type of vaccine may provide an answer to this global problem.' As Peer pointed out, the quick development of the COVID-19 vaccine was based on years of mRNA research for similar viruses. 6 The goal is for this new technology to fast-track vaccines for bacterial diseases, according to the researchers. AP 'If tomorrow we face some kind of bacterial pandemic, our study will provide a pathway for quickly developing safe and effective mRNA vaccines.' As this was a pre-clinical proof-of-concept study, Peer noted that several major milestones still need to be fulfilled before this vaccine could be considered for commercial rollout. However, he believes that in an emergency situation, the vaccine could be scaled up and prepared in a 'relatively short time.' Peer concluded, 'Beyond addressing the threat of plague outbreaks and potential bioterrorism, this study opens the door to developing mRNA vaccines against other antibiotic-resistant bacteria, offering a powerful new strategy to combat rising antimicrobial resistance and improve global pandemic preparedness.' The study was supported by the European Research Council, the Israel Institute for Biological Research and the Shmunis Family Foundation.
